Quantum Biopharma faces class action lawsuit
- Class action lawsuit against CIBC and RBC alleging stock market manipulation
- Court appointed Grant & Eisenhofer as lead counsel
- Allegations span from 2020 to 2025
QNTM
Quantum Biopharma Ltd. SEC filings
Every EDGAR filing for Quantum Biopharma Ltd. (QNTM), newest first, with AI summaries and stories.
- Ticker
- QNTM
- CIK
- 1771885
- Latest filing
- Oct 8
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
NOTABLE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE Quantum BioPharma signs trial contract
- Signed contract with Thermo Fisher for Phase 2 trial
- Phase 2 trial evaluates Lucid-MS for MS
- FDA cleared to proceed with trial
ROUTINESCHEDULE 13G/AQuantum Biopharma Ltd.QNTMLIVE Quantum Biopharma Ltd. shares held by AdvisorShares Trust
- AdvisorShares Trust holds 400,378 shares
- 4.95% of class owned
- Sole voting and dispositive power
AdvisorShares Trust
ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-K/AQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-K/AQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-K/AQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-K/AQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINESCHEDULE 13GQuantum Biopharma Ltd.QNTMLIVE Ownership stake disclosure by AdvisorShares Trust
AdvisorShares Trust, filed by
ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE NOTABLE20-FQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINESCHEDULE 13G/AQuantum Biopharma Ltd.QNTMLIVE Ownership stake disclosure by Malone Wealth Ventures LLC (amended)
Malone Wealth Ventures LLC, filed by
ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE424B5Quantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-K/AQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.QNTMLIVE ROUTINE6-KQuantum Biopharma Ltd.LIVE ROUTINE424B5Quantum Biopharma Ltd.LIVE